Skip to content
10-Q

Quarterly Report

CADENCE PHARMACEUTICALS INC

0001193125-13-430222

← back to feed
Filed
Nov 6, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 86.09M sh
Capex Q3 2013 · Sep 30, 2013 $80K
Capex Q3 2013 · Sep 30, 2012 $1.46M
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$23.84M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$51.34M
Long Term Debt Q3 2013 · Sep 30, 2013 $21.25M
Long Term Debt Q3 2013 · Dec 31, 2012 $28.82M
Short Term Debt Q3 2013 · Sep 30, 2013 $7.94M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $51.98M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $58.33M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $69.37M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $82.61M
Stockholders Equity Q3 2013 · Sep 30, 2013 $34.38M
Stockholders Equity Q3 2013 · Dec 31, 2012 $47.81M
Current Liabilities Q3 2013 · Sep 30, 2013 $27.79M
Current Liabilities Q3 2013 · Dec 31, 2012 $21M
Total Liabilities Q3 2013 · Sep 30, 2013 $49.64M
Total Liabilities Q3 2013 · Dec 31, 2012 $49.87M
Current Assets Q3 2013 · Sep 30, 2013 $70.97M
Current Assets Q3 2013 · Dec 31, 2012 $76.52M
Total Assets Q3 2013 · Sep 30, 2013 $84.02M
Total Assets Q3 2013 · Dec 31, 2012 $97.68M
Sga Expense Q3 2013 · Sep 30, 2013 $22.93M
Sga Expense Q3 2013 · Sep 30, 2013 $70.26M
Sga Expense Q3 2013 · Sep 30, 2012 $20.04M
Sga Expense Q3 2013 · Sep 30, 2012 $66.81M
Rd Expense Q3 2013 · Sep 30, 2013 $1.66M
Rd Expense Q3 2013 · Sep 30, 2013 $4.7M
Rd Expense Q3 2013 · Sep 30, 2012 $2.24M
Rd Expense Q3 2013 · Sep 30, 2012 $5.45M
Net Income Q3 2013 · Sep 30, 2013 −$6.94M
Net Income Q3 2013 · Sep 30, 2013 −$20.18M
Net Income Q3 2013 · Sep 30, 2012 −$15.89M
Net Income Q3 2013 · Sep 30, 2012 −$59.55M
Operating Income Q3 2013 · Sep 30, 2013 −$5.82M
Operating Income Q3 2013 · Sep 30, 2013 −$24.55M
Operating Income Q3 2013 · Sep 30, 2012 −$14.8M
Operating Income Q3 2013 · Sep 30, 2012 −$56.35M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $9.96M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $26.43M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $6.08M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $16.08M
Revenue Q3 2013 · Sep 30, 2013 $28.96M
Revenue Q3 2013 · Sep 30, 2013 $77.24M
Revenue Q3 2013 · Sep 30, 2012 $13.9M
Revenue Q3 2013 · Sep 30, 2012 $33.01M